Equine Rhinopneumonitis Vaccine Market, Global Outlook and Forecast 2022-2028

March 2022 | 72 pages | ID: EEE3311B93AEEN
Market Monitor Global

Abstracts

Equine Rhinopneumonitis Vaccine can prevent Equine Rhinopneumonitis?viruses that are prevalent in horses and can cause outbreaks of respiratory disease.

This report contains market size and forecasts of Equine Rhinopneumonitis Vaccine in global, including the following market information:

Global Equine Rhinopneumonitis Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Equine Rhinopneumonitis Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Equine Rhinopneumonitis Vaccine companies in 2021 (%)

The global Equine Rhinopneumonitis Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Live Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Equine Rhinopneumonitis Vaccine include Zoetis, Nisseiken Co., Ltd., Boehringer Ingelheim, Santa Cruz Animal Health and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Equine Rhinopneumonitis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Equine Rhinopneumonitis Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Equine Rhinopneumonitis Vaccine Market Segment Percentages, by Type, 2021 (%)

• Live
• Inactivated

Global Equine Rhinopneumonitis Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Equine Rhinopneumonitis Vaccine Market Segment Percentages, by Application, 2021 (%)

• Veterinary Pharmacy
• Online Sale
• Others

Global Equine Rhinopneumonitis Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Equine Rhinopneumonitis Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Equine Rhinopneumonitis Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Equine Rhinopneumonitis Vaccine revenues share in global market, 2021 (%)

Key companies Equine Rhinopneumonitis Vaccine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Equine Rhinopneumonitis Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Zoetis
• Nisseiken Co., Ltd.
• Boehringer Ingelheim
• Santa Cruz Animal Health
• Merck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Equine Rhinopneumonitis Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Equine Rhinopneumonitis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EQUINE RHINOPNEUMONITIS VACCINE OVERALL MARKET SIZE

2.1 Global Equine Rhinopneumonitis Vaccine Market Size: 2021 VS 2028
2.2 Global Equine Rhinopneumonitis Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Equine Rhinopneumonitis Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Equine Rhinopneumonitis Vaccine Players in Global Market
3.2 Top Global Equine Rhinopneumonitis Vaccine Companies Ranked by Revenue
3.3 Global Equine Rhinopneumonitis Vaccine Revenue by Companies
3.4 Global Equine Rhinopneumonitis Vaccine Sales by Companies
3.5 Global Equine Rhinopneumonitis Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Equine Rhinopneumonitis Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Equine Rhinopneumonitis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Equine Rhinopneumonitis Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Equine Rhinopneumonitis Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Equine Rhinopneumonitis Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Equine Rhinopneumonitis Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Live
  4.1.3 Inactivated
4.2 By Type - Global Equine Rhinopneumonitis Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Equine Rhinopneumonitis Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Equine Rhinopneumonitis Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Equine Rhinopneumonitis Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Equine Rhinopneumonitis Vaccine Sales & Forecasts
  4.3.1 By Type - Global Equine Rhinopneumonitis Vaccine Sales, 2017-2022
  4.3.2 By Type - Global Equine Rhinopneumonitis Vaccine Sales, 2023-2028
  4.3.3 By Type - Global Equine Rhinopneumonitis Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Equine Rhinopneumonitis Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Equine Rhinopneumonitis Vaccine Market Size, 2021 & 2028
  5.1.2 Veterinary Pharmacy
  5.1.3 Online Sale
  5.1.4 Others
5.2 By Application - Global Equine Rhinopneumonitis Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Equine Rhinopneumonitis Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Equine Rhinopneumonitis Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Equine Rhinopneumonitis Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Equine Rhinopneumonitis Vaccine Sales & Forecasts
  5.3.1 By Application - Global Equine Rhinopneumonitis Vaccine Sales, 2017-2022
  5.3.2 By Application - Global Equine Rhinopneumonitis Vaccine Sales, 2023-2028
  5.3.3 By Application - Global Equine Rhinopneumonitis Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Equine Rhinopneumonitis Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Equine Rhinopneumonitis Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Equine Rhinopneumonitis Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Equine Rhinopneumonitis Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Equine Rhinopneumonitis Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Equine Rhinopneumonitis Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Equine Rhinopneumonitis Vaccine Sales & Forecasts
  6.3.1 By Region - Global Equine Rhinopneumonitis Vaccine Sales, 2017-2022
  6.3.2 By Region - Global Equine Rhinopneumonitis Vaccine Sales, 2023-2028
  6.3.3 By Region - Global Equine Rhinopneumonitis Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Equine Rhinopneumonitis Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America Equine Rhinopneumonitis Vaccine Sales, 2017-2028
  6.4.3 US Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.4.4 Canada Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.4.5 Mexico Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Equine Rhinopneumonitis Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe Equine Rhinopneumonitis Vaccine Sales, 2017-2028
  6.5.3 Germany Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.5.4 France Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.5.5 U.K. Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.5.6 Italy Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.5.7 Russia Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.5.9 Benelux Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Equine Rhinopneumonitis Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia Equine Rhinopneumonitis Vaccine Sales, 2017-2028
  6.6.3 China Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.6.4 Japan Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.6.5 South Korea Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.6.7 India Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Equine Rhinopneumonitis Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America Equine Rhinopneumonitis Vaccine Sales, 2017-2028
  6.7.3 Brazil Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.7.4 Argentina Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Equine Rhinopneumonitis Vaccine Sales, 2017-2028
  6.8.3 Turkey Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.8.4 Israel Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia Equine Rhinopneumonitis Vaccine Market Size, 2017-2028
  6.8.6 UAE Equine Rhinopneumonitis Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Zoetis
  7.1.1 Zoetis Corporate Summary
  7.1.2 Zoetis Business Overview
  7.1.3 Zoetis Equine Rhinopneumonitis Vaccine Major Product Offerings
  7.1.4 Zoetis Equine Rhinopneumonitis Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 Zoetis Key News
7.2 Nisseiken Co., Ltd.
  7.2.1 Nisseiken Co., Ltd. Corporate Summary
  7.2.2 Nisseiken Co., Ltd. Business Overview
  7.2.3 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Major Product Offerings
  7.2.4 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales and Revenue in Global (2017-2022)
  7.2.5 Nisseiken Co., Ltd. Key News
7.3 Boehringer Ingelheim
  7.3.1 Boehringer Ingelheim Corporate Summary
  7.3.2 Boehringer Ingelheim Business Overview
  7.3.3 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Major Product Offerings
  7.3.4 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales and Revenue in Global (2017-2022)
  7.3.5 Boehringer Ingelheim Key News
7.4 Santa Cruz Animal Health
  7.4.1 Santa Cruz Animal Health Corporate Summary
  7.4.2 Santa Cruz Animal Health Business Overview
  7.4.3 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Major Product Offerings
  7.4.4 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales and Revenue in Global (2017-2022)
  7.4.5 Santa Cruz Animal Health Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Equine Rhinopneumonitis Vaccine Major Product Offerings
  7.5.4 Merck Equine Rhinopneumonitis Vaccine Sales and Revenue in Global (2017-2022)
  7.5.5 Merck Key News

8 GLOBAL EQUINE RHINOPNEUMONITIS VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Equine Rhinopneumonitis Vaccine Production Capacity, 2017-2028
8.2 Equine Rhinopneumonitis Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Equine Rhinopneumonitis Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 EQUINE RHINOPNEUMONITIS VACCINE SUPPLY CHAIN ANALYSIS

10.1 Equine Rhinopneumonitis Vaccine Industry Value Chain
10.2 Equine Rhinopneumonitis Vaccine Upstream Market
10.3 Equine Rhinopneumonitis Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Equine Rhinopneumonitis Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Equine Rhinopneumonitis Vaccine in Global Market
Table 2. Top Equine Rhinopneumonitis Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Equine Rhinopneumonitis Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Equine Rhinopneumonitis Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Equine Rhinopneumonitis Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Equine Rhinopneumonitis Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Equine Rhinopneumonitis Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Equine Rhinopneumonitis Vaccine Product Type
Table 9. List of Global Tier 1 Equine Rhinopneumonitis Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Equine Rhinopneumonitis Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Equine Rhinopneumonitis Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Equine Rhinopneumonitis Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Equine Rhinopneumonitis Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Equine Rhinopneumonitis Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Equine Rhinopneumonitis Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Equine Rhinopneumonitis Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Equine Rhinopneumonitis Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Equine Rhinopneumonitis Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Equine Rhinopneumonitis Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Equine Rhinopneumonitis Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Equine Rhinopneumonitis Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Equine Rhinopneumonitis Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Equine Rhinopneumonitis Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Equine Rhinopneumonitis Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Equine Rhinopneumonitis Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Equine Rhinopneumonitis Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Equine Rhinopneumonitis Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Equine Rhinopneumonitis Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Equine Rhinopneumonitis Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Equine Rhinopneumonitis Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Equine Rhinopneumonitis Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Equine Rhinopneumonitis Vaccine Sales, (K Units), 2023-2028
Table 46. Zoetis Corporate Summary
Table 47. Zoetis Equine Rhinopneumonitis Vaccine Product Offerings
Table 48. Zoetis Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Nisseiken Co., Ltd. Corporate Summary
Table 50. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product Offerings
Table 51. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Boehringer Ingelheim Corporate Summary
Table 53. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product Offerings
Table 54. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Santa Cruz Animal Health Corporate Summary
Table 56. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product Offerings
Table 57. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Merck Corporate Summary
Table 59. Merck Equine Rhinopneumonitis Vaccine Product Offerings
Table 60. Merck Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Equine Rhinopneumonitis Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global Equine Rhinopneumonitis Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Equine Rhinopneumonitis Vaccine Production by Region, 2017-2022 (K Units)
Table 64. Global Equine Rhinopneumonitis Vaccine Production by Region, 2023-2028 (K Units)
Table 65. Equine Rhinopneumonitis Vaccine Market Opportunities & Trends in Global Market
Table 66. Equine Rhinopneumonitis Vaccine Market Drivers in Global Market
Table 67. Equine Rhinopneumonitis Vaccine Market Restraints in Global Market
Table 68. Equine Rhinopneumonitis Vaccine Raw Materials
Table 69. Equine Rhinopneumonitis Vaccine Raw Materials Suppliers in Global Market
Table 70. Typical Equine Rhinopneumonitis Vaccine Downstream
Table 71. Equine Rhinopneumonitis Vaccine Downstream Clients in Global Market
Table 72. Equine Rhinopneumonitis Vaccine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Equine Rhinopneumonitis Vaccine Segment by Type
Figure 2. Equine Rhinopneumonitis Vaccine Segment by Application
Figure 3. Global Equine Rhinopneumonitis Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Equine Rhinopneumonitis Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Equine Rhinopneumonitis Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Equine Rhinopneumonitis Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Equine Rhinopneumonitis Vaccine Revenue in 2021
Figure 9. By Type - Global Equine Rhinopneumonitis Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Equine Rhinopneumonitis Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Equine Rhinopneumonitis Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Equine Rhinopneumonitis Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Equine Rhinopneumonitis Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Equine Rhinopneumonitis Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Equine Rhinopneumonitis Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Equine Rhinopneumonitis Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Equine Rhinopneumonitis Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Equine Rhinopneumonitis Vaccine Sales Market Share, 2017-2028
Figure 19. US Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Equine Rhinopneumonitis Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Equine Rhinopneumonitis Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Equine Rhinopneumonitis Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Equine Rhinopneumonitis Vaccine Sales Market Share, 2017-2028
Figure 33. China Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Equine Rhinopneumonitis Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Equine Rhinopneumonitis Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Equine Rhinopneumonitis Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Equine Rhinopneumonitis Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Equine Rhinopneumonitis Vaccine by Region, 2021 VS 2028
Figure 50. Equine Rhinopneumonitis Vaccine Industry Value Chain
Figure 51. Marketing Channels